D.C.-based The Advisory Board Co. saw its share price jump Friday after reporting a 90 percent year-over-year increase in first-quarter net income, beating analyst expectations.
The improved margins come after the health and education consultancy embarked on a cost-cutting mission, resulting in $11.2 million in restructuring-related charges. Advisory Board also reported a $23.4 million gain from selling Evolent Health stock during the quarter. For the first quarter, Advisory Board (NASDAQ: ABCO)…
D.C.-based The Advisory Board Co. saw its share price jump Friday after reporting a 90 percent year-over-year increase in first-quarter net income, beating analyst expectations.
The improved margins come after the health and education consultancy embarked on a cost-cutting mission, resulting in $11.2 million in restructuring-related charges. Advisory Board also reported a $23.4 million gain from selling Evolent Health stock during the quarter. For the first quarter, Advisory Board (NASDAQ: ABCO)…